:: American Parkinson Disease Association ::Fellowship And Grants

FELLOWSHIPS AND RESEARCH GRANTS ANNOUNCEMENT


ACADEMIC YEAR 2010-2011

The American Parkinson Disease Association will be accepting applications for the Medical Student Summer Fellowships for 2011. Applications are to be submitted electronically by January 31, 2011. The American Parkinson Disease Association continues to fund for Research Grants, Postdoctoral Fellowships, the Cotzias Memorial Fellowships, the Roger Duvoisin Research Grants and Centers for Advanced Research. You may contact Michele Popadynec, RN, MPS at 800 223-2732 ext. 118 or via email at www.mpopadynec@apdaparkinson.org for more information.
Medical Students Summer Fellowships
The APDA Summer Fellowships are designed to provide a stipend to enable medical students to perform supervised laboratory or clinical research designed to clarify our understanding of Parkinson’s disease, its nature, manifestations, etiology or treatment. It is hoped this experience will stimulate a student’s interest in future research in the field of Parkinson’s disease and related disorders.This is a Fellowship of $4,000 for a three(3) month summer commitment.
DeadLine	1/31/2011 Details
Fellowship Student Application

APDA Funded Research

George C. Cotzias, MD Memorial Fellowships
David Hinkle, MD, Ph.D. University of Pittsburgh Pittsburg, PA	The Potential Role of Antioxidant Systems in the Mechanism of DJ-1 Dependent Astrocytemediated Neuroprotection

Bradley Miller, MD, Ph.D. University of Virginia Charlottesville, VA	Distribution and Metabolic Consequences of Mitochondrial DNA Deletions in Substantia Nigra and Cultured Cells

Talene Yacoubian, MD, Ph.D. The University of Alabama Birmingham, Al	Role of 14-3-3 Proteins in Alpha Synuclein Induced Neurotoxicity


Roger C. Duvoisin, MD, Research Grant
Andrei Alexandrescu, Ph.D. University of Connecticut Storrs, CT	Stability and Solvent Accessibility of Alpha-Synuclein Fibrils by NMR Hydrogen Exchange

Jeffrey Stock, Ph.D. Princeton University Princeton, NJ	Protein Phosphatase 2A Methylation as a Therapeutic Target for Parkinson’s Disease

Marc Tatar, Ph.D. Brown University Providence, RI	Assessing the Pathogenic and Molecular Consequences of FOXO Regulation by Parkin


Research Grants
Hans Bueler, Ph.D. University of Kentucky Lexington, KY	Identification of PINK1 Substrates Using Conditional PINK1 Knockout Cells and Quantitative Phosphoproteomics

Ippolita Castelvetri, Ph.D. Massachusetts General Hospital Charlestown, MA	Biological Basis for Diferential Susceptibility to Alpha-Synuclein Pathology in the Male and Femal Human Brain

Savio Chan, Ph.D. Northwestern University Chicago, IL	Sriatopallidal GABAergic Signaling in Mouse Models of Parkinson’s Disease

Linan Chen, MD, Ph.D. University of Chicago Chicago, IL	Transgenic Overexpression Selectively in Dopamine Neurons via Controlled Genetic Amplification

Shu Chen, Ph.D. Case Western Reserve University Cleveland, OH	Transgenic C. Elegans Model of LRRK2-Linked Parkinson Disease

Shankar Chinta, Ph.D. Buck Institute for Age Research Novato, CA	Potential Neuroprotective Role of Resveratrol in Parkinson’s Disease Mouse Models

Paul Davenport, Ph.D. University of Florida Gainesville, FL	Central Neural Gating of Pharyngeal Mechanically Elicited Cortical Evoked Potentials (CEP): An Evaluation of Swallow Neural Integration in Parkinson’s Disease (PD)

Wei Ming Duan, MD, Ph.D. Louisiana State University Shreveport, LA	Generation of Dopaminergic Neurons from Endogenous Stem Cells in the Brain of a Mouse Model of Parkinson’s Disease

Jian Feng, Ph.D. State University of New York Buffalo, NY	Generating Patient –Specific Induced Pluripotent Stem Cells to Study Parkinson’s Disease

Matthew Goldberg, Ph.D. UT Southwestern Medical Center Dallas, TX	Parkin, DJ-1 and Glutathione Peroxidase-Deficient Mouse Models of PD

Steven Johnson, MD, Ph.D. Portland VA Research Portland, OR	Redox Regulation of NMDA Currents in Midbrain Dopamine Neurons





Gerardo Morfini, Ph.D. University of Illinois Chicago, IL	Molecular Mechanisms Underlying MPP+ Induced Activation of Cytoplamic Dynein-Based Vesicle Transport

Anthony Nicholas, MD, Ph.D. University of Alabama Birmingham, AL	Gene Analysis of Histone Deacetylation in Levodopa-Induced Dyskinesia and Priming

Arnulfo Quesada, Ph.D. Brentwood Biomedical Research Institute Los Angeles, CA	A Promising New Protective Factor for Parkinson’s Disease



Jean Rochet, Ph.D. Purdue University West Lafayette, IN	Role of ATP13A2 (PARK9) Dysfunction in Parkinson’s Disease

Subhojit Roy, Ph.D. University of California Jolla, CA	Effects of Alpha-Synuclein on Fast and Slow Axonal Transport

Derek Siebruth, Ph.D. University of Southern California Los Angeles, CA	Large Scale Analysis of Synaptic Architecture in Alphasynuclein Expressing Neurons

Wanli Smith, MD, Ph.D. Johns Hopkins University School of Med. Baltimore, MD	Autophagy and LRRK2-Linked Parkinsonism

Shaji Theodore, Ph.D. University of Alabama Birmingham, AL	Inhibiting Nuclear Factor Kappa B Signaling and Microglial Activation in a Mouse Model of Parkinson’s Disease

Enrique Torre, Ph.D. Emory University Atlanta, GA	Significance of mRNA Transport and Translation within the Dopaminergic Axon

Kala Venkiteswaran, Ph.D. Penn State Hershey College of Medicine Hershey, PA	Transplantation of Transdifferentiated Dopaminergic Neurons Derived from Human Retinal Pigment Epithelial Cells

Harrison Walker, MD University of Alabama Birmingham, AL	Bilateral Clinical and Neurophysiological Effects of Unilateral STN DBS in PD

Gaofeng Wang, Ph.D. University of Miami Coral Gables, FL	The Role of miRNA in Olfactory Deficit of Parkinson’s Disease

Andrew West, Ph.D. University of Alabama Birmingham, AL	Development of Cell Based Kinase Assays for LRRK2



Fu-Ming Zhou, MD, Ph.D. University of Tennessee Memphis, TN	An Ultra Short Dopamine Pathway: Part II. Signaling Mechanisms

Jianhui Zhu, Ph.D. University of Pittsburgh Pittsburgh, PA	ATP13A2 and Autolysosomal Pathology in Parkinson’s Disease

Xiongwei Zhu, Ph.D. Case Western Reserve University Cleveland, OH	Role of Impaired Mitochondrial Dynamics in Mutant LRRK2 Induced Toxicity




Post-Doctoral Fellowships
Jason Cannon, Ph.D. University of Pittsburgh Pittsburgh, PA	Genetic and Environmental Interactions in Parkinson’s Disease: Potential for New Therapeutic Pathways

William Caudle, Ph.D. University of Washington Seattle, WA	Proteomic Analysis of VMAT2 under Normal and Pathological Conditions

Yeun Su Choo, Ph.D. Burnham Institute for Medical Research La Jolla, CA	Regulation of Parkin by Neddylation



Gizem Donmez, Ph.D. Massachusetts Institute of Technology Cambridge, MA	Analysis of the Role of SIRT2 Protein in Parkinson’s Disease

Robert Drolet, Ph.D. University of Pittsburgh Pittsburgh, PA	Gastrointestinal Dysfunction in the Rotenone Model of Parkinson’s Disease

Muralidhar Hedge, Ph.D. Uiversity of Texas Galveston, TX	Role of Transition Metals in Inhibiting Repair of Oxidized Bases in Genome: Relevance to Parkinson’s Disease

William Lin, Ph.D. University of Chicago Chicago, IL	Mechanism and Function of Cytosolic PINK1

Zhihui Sun, Ph.D. University of Pennsylvania Philadelphia, PA	Investigating Synuclein Gene FunctionIn Zebrafish

Daniel Tardiff, Ph.D. Whitehead Institute for Biomedical Res. Cambridge, MA	Mitochondrial Proteomics of a Yeast Parkinson’s Disease Model

Ravindar Thomas, Ph.D. University of Virginia Charlottesville, VA	Development of Mitochondrial Gene Therapy for Parkinson’s Disease

Yulan Xiong, Ph.D. Johns Hopkins University Baltimore, MD	Modeling LRRK2-Induced Toxicity in Yeast

Nanyan Zhang, Ph.D. University of Colorado Aurora, CO	Delineating Protein Coaggregation during Lewy Body Formation


Medical Students Summer Fellowships
Grant Aaker Weill Cornell Medical College New York, NY	Detection of Retinal Changes in PD with Optical Coherence

Shivraj Bhosle Burke Medical Research Institute/Weill Cornell Medical College New York, NY	Region Specific Regulation of Gene Expression in Dopamine Neurons

Nirmish Singla University of Michigan Medical School Ann Arbor, MI	Evaluation of Lead Placement in Deep Brain Stimulation with Post-op Cognitive and Behavioral Outcome

Minhong Yu University of Virginia Charlottesville, NC	Rhythmic Perception in Parkinson Disease






Centers for Advanced Research
University of Alabama David Standaert, MD Birmingham, AL	UCLA School of Medicine Marie Francois Chesslet, MD, PhD Los Angeles, CA

Emory University School of Medicine Mahlon DeLong, MD Atlanta, GA	The University of Chicago Un Jung Kang, MD Chicago, IL

Boston University School of Medicine Marie St. Hilaire, MD Boston, MA	Washington University Medical Center Joel Perlmutter, MD St. Louis, MO

Robert Wood Johnson Medical School Jacob Sage, MD New Brunswick, NJ	University of Pittsburgh J. Timothy Greenamyre, MD, PhD Pittsburgh, PA

University of Virginia Medical Center Frederick G. Wooten, MD Charlottesville, VA